Literature DB >> 25310620

A study on allergen sensitivity in patients with allergic rhinitis in Bangalore, India.

G Gowda1, S Lakshmi2, B G Parasuramalu1, C Nagaraj1, B V C Gowda2, K G Somashekara2.   

Abstract

BACKGROUND: Allergic rhinitis is the most common form of non-infectious rhinitis, affecting 500 million people worldwide, with one-fifth of those affected living in the Indian subcontinent. The skin prick test is the most valuable test for detecting offending allergens, and can be helpful for patient education, allergen avoidance and immunotherapy planning.
METHOD: The skin prick test was performed with 49 allergens in 486 patients who presented with symptoms of allergic rhinitis, and the allergen profile was studied.
RESULTS: Of the 486 allergic rhinitis patients, 335 (68.93 per cent) showed allergen positivity to the skin prick test. Dust mite was the most common allergen, with positive results in 44.65 per cent of cases.
CONCLUSION: The most common offending allergen in our study was the dust mite. Identification of specific allergens for a particular geographical area aids patient education and enables allergen-specific immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25310620     DOI: 10.1017/S0022215114001984

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Clinical Efficacy of Sanfeng Tongqiao Diwan in the Treatment of Allergic Rhinitis: A Randomized Controlled Trial.

Authors:  Jing Ma; Jiaying Luo; Zhangkai Cheng; Gui Chen; Zhiman Liang; Baoqing Sun; Feng Wang
Journal:  Dis Markers       Date:  2022-06-25       Impact factor: 3.464

2.  Trends of sensitization pattern to aeroallergens among the patients with allergic rhinitis and/or bronchial asthma in Bangalore: A cross sectional study.

Authors:  Gianchand Shikha; Himanshu Swami
Journal:  Med J Armed Forces India       Date:  2021-02-26

3.  Proteomic profiling of commercial dust mite skin prick test solutions and allergy vaccines from India.

Authors:  Sara Huber; Gabriele Gadermaier; Barbara Bohle; Fatima Ferreira; Peter Briza
Journal:  World Allergy Organ J       Date:  2021-02-26       Impact factor: 4.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.